[ Price : $8.95]
FDA accepts for review a Merck supplemental BLA for Keytruda in combination with standard-of-care chemotherapy for treating patien...[ Price : $8.95]
FDA approves an Avita Medical PMA supplement for use of its Recell System to treat full-thickness skin defects.[ Price : $8.95]
Federal Register notice: FDA determines that Bristol Myers Squibbs Buspar (buspirone HCl) was not withdrawn due to safety or effec...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Importation of Prescription Drugs 21 ...[ Price : $8.95]
Federal Register notice: FDA renews its Antimicrobial Drugs Advisory Committee for an additional two years.[ Price : $8.95]
FDA names CDER Office of Generic Drugs safety and clinical evaluation acting director Iilun Murphy as the next OGD director, repla...[ Price : $8.95]
FDA greenlights commercial production of CAR T cell therapy at a new Bristol Myers Squibb manufacturing site in Devens, MA.[ Price : $8.95]
FDAs Antimicrobial Drugs Advisory Committee votes unanimously that AstraZeneca and Sanofis nirsevimab has a favorable benefit-risk...